IL9 and breast cancer: Together, these data indicated an inflammatory response for IL-9-producing CD8+ T-cells in BC, and the low expression of PD-1 on IL-9RHi CD8 + T-cells may indicate that these cells are more resistant to inhibitory mechanisms in the tumor microenvironment, enabling them to perform effector functions more effectively [113].